OncoSec Medical (LTS:0KC7) Cyclically Adjusted FCF per Share: $-204.48 (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0KC7 OncoSec Medical Inc LTS:0KC7
40 GF Score
Price $143.00
View Full Analysis

What is OncoSec Medical Cyclically Adjusted FCF per Share?

OncoSec Medical LTS:0KC7 40 Cyclically Adjusted FCF per Share is $-204.48 as of Jan. 2023. GuruFocus rates LTS:0KC7 with a GF Score™ of 40/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

OncoSec Medical's adjusted free cash flow per share for the three months ended in Jan. 2023 was $-2.561. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-204.48 for the trailing ten years ended in Jan. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-09-17), OncoSec Medical's current stock price is $143.00. OncoSec Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2023 was $-204.48. OncoSec Medical's Cyclically Adjusted Price-to-FCF of today is .


OncoSec Medical  (LTS:0KC7) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


OncoSec Medical Cyclically Adjusted FCF per Share Related Terms


OncoSec Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Cyclically Adjusted FCF per Share Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -184.12 -196.25 -202.50 -204.68 -187.88

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -224.42 -223.43 -217.30 -211.07 -204.48

LTS:0KC7 vs NOVNQ, USRM, VRTX: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, OncoSec Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoSec Medical Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Cyclically Adjusted Price-to-FCF falls into.


LTS:0KC7
40GF Score
OncoSec Medical Inc LTS:0KC7
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoSec Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, OncoSec Medical's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jan. 2023 (Change)*Current CPI (Jan. 2023)
=-2.561/299.1700*299.1700
=-2.561

Current CPI (Jan. 2023) = 299.1700.

OncoSec Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201304 -61.706 232.531 -79.390
201307 -52.140 233.596 -66.777
201310 -63.033 233.546 -80.745
201401 -45.258 233.916 -57.883
201404 -53.858 237.072 -67.965
201407 -55.223 238.250 -69.343
201410 -69.483 237.433 -87.550
201501 -72.675 233.707 -93.032
201504 -93.703 236.599 -118.484
201507 -87.462 238.654 -109.640
201510 -76.251 237.838 -95.914
201601 -64.802 236.916 -81.830
201604 -62.566 239.261 -78.232
201607 -54.431 240.628 -67.673
201610 -51.287 241.729 -63.474
201701 -42.510 242.839 -52.371
201704 -47.548 244.524 -58.174
201707 -47.219 244.786 -57.710
201710 -50.075 246.663 -60.734
201801 -38.840 247.867 -46.879
201804 -25.209 250.546 -30.101
201807 -25.635 252.006 -30.433
201810 -27.017 252.885 -31.962
201901 -22.620 251.712 -26.885
201904 -253.958 255.548 -297.309
201907 -16.744 256.571 -19.524
201910 -16.799 257.346 -19.529
202001 -15.281 257.971 -17.721
202004 -8.229 256.389 -9.602
202007 -8.934 259.101 -10.316
202010 -8.003 260.388 -9.195
202101 -8.325 261.582 -9.521
202104 -7.694 267.054 -8.619
202107 -4.749 273.003 -5.204
202110 -5.542 276.589 -5.994
202201 -5.740 281.148 -6.108
202204 -2.985 289.109 -3.089
202207 -3.864 296.276 -3.902
202210 -3.422 298.012 -3.435
202301 -2.561 299.170 -2.561

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-204.48 mean?
OncoSec Medical (LTS:0KC7) has a Cyclically Adjusted FCF per Share of $-204.48 as of Jan. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Cyclically Adjusted FCF per Share too high?
OncoSec Medical's current Cyclically Adjusted FCF per Share is $-204.48. Overall, OncoSec Medical has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does OncoSec Medical's Cyclically Adjusted FCF per Share compare to NOVNQ and USRM?
OncoSec Medical's Cyclically Adjusted FCF per Share of $-204.48 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Cyclically Adjusted FCF per Share is $-204.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (LTS:0KC7) has a current Cyclically Adjusted FCF per Share of $-204.48. The current Cyclically Adjusted FCF per Share is $-204.48. OncoSec Medical's overall GF Score™ is 40/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For OncoSec Medical (LTS:0KC7), the current Cyclically Adjusted FCF per Share is $-204.48 as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.
40GF Score

Get the complete analysis for LTS:0KC7

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$143.00
Price